Oral Melatonin as Neuroprotectant in Preterm Infants

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 25, 2020

Primary Completion Date

October 1, 2022

Study Completion Date

October 11, 2022

Conditions
MalondialdehydeMelatonin
Interventions
DIETARY_SUPPLEMENT

melatonin

orally administered drops

DRUG

placebo

orally administered drops

Trial Locations (4)

25123

"Child and Adolescence Neuropsychiatry Unit, Children's Hospital Spedali Civili of Brescia, 25123 Brescia, Italy.", Brescia

"Neonatal Intensive Care Unit, Children's Hospital, University Hospital Spedali Civili Brescia, 25123 Brescia, Italy.", Brescia

27100

Fondazione IRCCS Mondino, Pavia

Neonatal Unit and NICU, Radiology, Clinical Chemistry Lab., Fondazione IRCCS Policlinico S. Matteo., Pavia

All Listed Sponsors
collaborator

"IRCCS National Neurological Institute C. Mondino Foundation"

OTHER

collaborator

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OTHER

lead

Francesca Garofoli

OTHER

NCT04235673 - Oral Melatonin as Neuroprotectant in Preterm Infants | Biotech Hunter | Biotech Hunter